Renal Cell Cancer and Chronic Kidney Disease

Adv Chronic Kidney Dis. 2021 Sep;28(5):460-468.e1. doi: 10.1053/j.ackd.2021.10.008.

Abstract

The association between chronic kidney disease (CKD) and renal cell carcinoma (RCC) is bidirectional and multifactorial. Risk factors such as hypertension, diabetes mellitus, obesity, and smoking increase the risk of both CKD and RCC. CKD can lead to RCC via an underlying cystic disease or oxidative stress. RCC can cause CKD because of the tumor itself, surgical reduction of renal mass (either partial or radical nephrectomy), and perioperative acute kidney injury. Medical therapies such as immune checkpoint inhibitors and vascular endothelial growth factor inhibitors can lead to acute kidney injury and resultant CKD. Clinicians need to be aware of the complex, bidirectional interplay between both diseases.

Keywords: CKD; ICI; RCC; VEGF-Inhibitor.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Carcinoma, Renal Cell* / complications
  • Carcinoma, Renal Cell* / pathology
  • Humans
  • Kidney Neoplasms* / etiology
  • Kidney Neoplasms* / therapy
  • Nephrectomy / adverse effects
  • Renal Insufficiency, Chronic* / complications
  • Vascular Endothelial Growth Factor A

Substances

  • Vascular Endothelial Growth Factor A